Ramsay Health Care (AU:RHC)
ASX:RHC
Top Page
Ramsay Health Care
(Sydney:RHC)
Select Model
Select Model
Rating:54Neutral
Price Target:
AU$42.00
▲(5.53% Upside)
Action:ReiteratedDate:11/26/25
Ramsay Health Care's overall stock score is primarily influenced by its financial performance and technical analysis. While the company shows stable revenue growth, high leverage and declining profitability are concerns. The technical indicators suggest short-term bullish momentum, but overbought signals indicate caution. The high P/E ratio suggests overvaluation, impacting the overall score negatively.
Positive Factors
Consistent revenue growth
Sustained revenue growth demonstrates persistent demand for Ramsay's hospital and elective services across markets. Durable topline expansion supports higher facility utilisation, helps amortize fixed costs, and provides a foundation for reinvestment in capacity and clinical capabilities over the next 2–6 months.
Negative Factors
High financial leverage
Very elevated leverage materially raises refinancing, interest and covenant risk and constrains capital allocation. In a capital-intensive hospital business, a debt-to-equity near 2.4 reduces strategic flexibility and increases vulnerability to rate moves or cash flow shocks over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent revenue growth
Sustained revenue growth demonstrates persistent demand for Ramsay's hospital and elective services across markets. Durable topline expansion supports higher facility utilisation, helps amortize fixed costs, and provides a foundation for reinvestment in capacity and clinical capabilities over the next 2–6 months.
Read all positive factors
Ramsay Health Care (RHC) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$9.14B
Dividend Yield2.25%
Average Volume (3M)804.76K
Price to Earnings (P/E)12.3
Beta (1Y)1.18
Revenue Growth6.82%
EPS Growth-99.27%
CountryAU
Employees90,000
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)0.71
Shares Outstanding230,829,800
10 Day Avg. Volume739,925
30 Day Avg. Volume804,756
Financial Highlights & Ratios
PEG Ratio-12.47
Price to Book (P/B)5.91
Price to Sales (P/S)1.67
P/FCF Ratio42.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$41.61Price Target Upside4.56% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)1.37
Revenue Forecast (FY)AU$18.98B
Ramsay Health Care Business Overview & Revenue Model
Company Description
Ramsay Health Care Limited owns and operates hospitals. The company also offers health care services to public and private patients. It operates facilities in approximately 532 locations in the Asia Pacific, the United Kingdom, France, and Nordics...
How the Company Makes Money
Ramsay Health Care primarily makes money by delivering hospital-based care and charging for episodes of care provided in its facilities. The core revenue stream is patient service revenue generated from admissions and procedures performed in its h...
Ramsay Health Care Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
60
Neutral
Cash Flow
70
Positive
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.59B | 17.79B | 16.66B | 14.96B | 13.08B | 12.86B |
| Gross Profit | 1.96B | 2.12B | 1.61B | 1.27B | 9.97B | 1.59B |
| EBITDA | 1.66B | 1.59B | 1.81B | 1.78B | 1.61B | 1.80B |
| Net Income | 289.60M | 24.00M | 888.70M | 298.10M | 274.00M | 449.00M |
Balance Sheet | ||||||
| Total Assets | 21.70B | 22.48B | 20.89B | 21.03B | 19.47B | 19.32B |
| Cash, Cash Equivalents and Short-Term Investments | 469.00M | 785.60M | 662.30M | 656.10M | 314.20M | 1.00B |
| Total Debt | 17.53B | 12.16B | 10.94B | 11.89B | 10.70B | 10.55B |
| Total Liabilities | 15.97B | 16.77B | 15.37B | 16.21B | 14.95B | 14.77B |
| Stockholders Equity | 5.04B | 5.02B | 4.90B | 4.15B | 3.93B | 4.03B |
Cash Flow | ||||||
| Free Cash Flow | 719.10M | 704.20M | 539.00M | 558.70M | 7.00M | 852.30M |
| Operating Cash Flow | 1.54B | 1.48B | 1.29B | 1.28B | 715.50M | 1.48B |
| Investing Cash Flow | -811.20M | -765.30M | 159.70M | -713.80M | 30.00M | -2.50B |
| Financing Cash Flow | -621.40M | -631.20M | -1.45B | -242.40M | -1.41B | 584.00M |
Ramsay Health Care Technical Analysis
Neutral
39.80
Price Trends
38.39
Positive
35.96
Positive
35.51
Positive
Market Momentum
0.59
Positive
47.45
Neutral
13.48
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:RHC, the sentiment is Neutral. The current price of 39.8 is below the 20-day moving average (MA) of 41.40, above the 50-day MA of 38.39, and above the 200-day MA of 35.51, indicating a neutral trend. The MACD of 0.59 indicates Positive momentum. The RSI at 47.45 is Neutral, neither overbought nor oversold. The STOCH value of 13.48 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:RHC.
Ramsay Health Care Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | AU$9.86B | 10.64 | 6.39% | 4.69% | 9.44% | -0.37% | |
59 Neutral | AU$367.14M | 23.92 | 16.35% | 4.60% | 6.73% | 37.16% | |
56 Neutral | AU$1.86B | 39.00 | ― | 2.30% | 14.61% | ― | |
55 Neutral | AU$905.69M | 26.42 | 2.05% | 2.65% | 33.54% | ― | |
54 Neutral | AU$9.14B | 12.30 | 5.75% | 2.25% | 6.82% | -99.27% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
46 Neutral | AU$403.00M | -5.40 | -67.21% | ― | -23.02% | 33.11% |
* Healthcare Sector Average
AU:RHC
Ramsay Health Care
39.80
7.05
21.52%
AU:HLS
Healius Limited
0.56
-0.42
-43.37%
AU:REG
Regis Healthcare Ltd.
6.16
-0.25
-3.98%
AU:SHL
Sonic Healthcare Limited
19.96
-4.60
-18.73%
AU:IDX
Integral Diagnostics Ltd.
2.43
0.22
10.05%
AU:ACL
Australian Clinical Labs Ltd
1.94
-0.90
-31.65%
Ramsay Health Care Corporate Events
Ramsay Health Care Confirms April 2026 Dividend on RHCPA Securities
Feb 25, 2026
Ramsay Health Care has confirmed that its board has now resolved to pay the dividend on its RHCPA transferable preference securities, in line with the CARES terms of issue set out in the 2005 prospectus. This satisfies the condition attached to an...
Ramsay Health Care Declares Interim Dividend of AUD 0.425 per Share
Feb 25, 2026
Ramsay Health Care Limited, a major private hospital and health care operator, has announced an interim dividend on its ordinary fully paid shares for the half-year period ended 31 December 2025. The distribution underscores the company’s on...
Ramsay Health Care Sets Out Key Financial and AGM Dates for 2026
Feb 25, 2026
Ramsay Health Care has released its proposed calendar of key financial and corporate dates for 2026, including the timing of interim and full-year results, dividend record and payment dates for ordinary shares and CARES, and the date of its Annual...
Ramsay Health Care Issues Unaudited 1H FY26 Results Overview With Risk Caveats
Feb 25, 2026
Ramsay Health Care has released its results presentation for the first half of fiscal year 2026, covering the six months ended 31 December 2025, led by Group CFO Anthony Neilson and Managing Director and Group CEO Natalie Davis. The presentation p...
Ramsay Health Care Releases HY26 Half-Year Financial Report
Feb 25, 2026
Ramsay Health Care has released its Appendix 4D half-year financial report for the six months ended 31 December 2025, marking the disclosure of its HY26 results to the market. The company will present these results via a webcast briefing hosted by...
Ramsay Health Care to Spin Off European Unit Ramsay Santé to Shareholders
Feb 19, 2026
Ramsay Health Care plans to separate its 52.79% stake in French-listed Ramsay Santé by distributing those shares in-specie to existing Ramsay shareholders, who would receive proportional interests via CHESS Depositary Interests tradeable on t...
Ramsay Health Care Issues New Unquoted Performance Rights Under Employee Incentive Plan
Jan 12, 2026
Ramsay Health Care Limited has notified the market of the issue of 291,857 unquoted performance rights under its employee incentive scheme, with an issue date of 15 December 2025. The additional performance rights, which will not be quoted on the ...
Ramsay Health Care Reports Lapse of 12,889 Performance Rights
Jan 12, 2026
Ramsay Health Care has notified the ASX of the cessation of 12,889 performance rights (security code RHCAB) that lapsed on 31 December 2025 because the conditions attached to those rights were not met or became incapable of being satisfied. The la...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.